Newsfeeds Archive - Spark Newswire

1 minute read

News

Reported Saturday, Akero Therapeutics Presented Data Highlighting The Efficacy And Safety Of EFX In Patients With MASH At EASL Congress

June 10, 3:44 AM

A late-breaking oral presentation will feature 96-week data from HARMONY, a Phase 2b study evaluating the efficacy and safety of EFX in patients with metabolic dysfunction-associated steatohepatitis (MASH), fibrosis

AKRO

2 minute read

What’s Going On With Fattly Liver Disease Focused Madrigal Pharmaceuticals, Sagimet Biosciences Shares On Wednesday?

By Vandana Singh

June 5, 3:17 PM

Madrigal Pharmaceuticals and Sagimet Biosciences shares fall following Eli Lilly's presentation at the EASL Liver Congress 2024. Phase 2 tirzepatide trial shows promising results for MASH treatment. Further trials needed to confirm efficacy and safety.

AKRO

1 minute read

Movers

12 Health Care Stocks Moving In Tuesday’s Pre-Market Session

By Benzinga Insights

February 6, 9:06 AM

Gainers Exicure (NASDAQ:XCUR) shares rose 55.5% to $0.87 during Tuesday’s pre-market session. The market value of their outstanding…

ADAP

2 minute read

Analyst Ratings

11 Analysts Have This to Say About Akero Therapeutics

By Benzinga Insights

November 14, 9:00 AM

Over the past 3 months, 11 analysts have published their opinion on Akero Therapeutics (NASDAQ:AKRO) stock. These analysts…

AKRO

1 minute read

Earnings

Akero Therapeutics: Q3 Earnings Insights

By Benzinga Insights

November 13, 10:40 AM

Akero Therapeutics (NASDAQ:AKRO) reported its Q3 earnings results on Monday, November 13, 2023 at 07:00 AM. Here’s what…

AKRO

3 minute read

Benzinga’s ‘Stock Whisper’ Index: 5 Stocks Investors Secretly Monitor But Don’t Talk About Yet

By Chris Katje

October 13, 10:26 AM

Investors are constantly on the hunt for undervalued, under-followed and emerging stocks. With countless methods available to retail traders, the challenge often lies in sifting through the abundance to uncover new information.

AKRO

1 minute read

E2open, Sharecare And Other Big Stocks Moving Lower In Thursday’s Pre-Market Session

By Lisa Levin

October 12, 5:58 AM

U.S. stock futures traded higher this morning on Thursday. Here are some big stocks recording losses in today’s pre-market trading session.

AKRO

1 minute read

Akero Therapeutics’ Lead Candidate Potential: Analyst Unpacks Complicated Regulatory Path Forward

By Vandana Singh

October 11, 3:35 PM

Tuesday, Akero Therapeutics Inc (NASDAQ: AKRO) reported a 36-week analysis of SYMMETRY, a 96-week Phase 2b study of efruxifermin (EFX) in patients with compensated cirrhosis (F4) due to nonalcoholic steatohepatitis (NASH).

AKRO

3 minute read

Movers

12 Health Care Stocks Moving In Wednesday’s Intraday Session

By Benzinga Insights

October 11, 1:31 PM

Gainers Tempest Therapeutics (NASDAQ:TPST) stock rose 1642.4% to $4.18 during Wednesday’s regular session. The current volume of 141.8…

AKRO

5 minute read

Why Astra Space Shares Are Trading Lower By 22%? Here Are Other Stocks Moving In Wednesday’s Mid-Day Session

By Lisa Levin

October 11, 1:13 PM

Gainers Tempest Therapeutics, Inc. (NASDAQ: TPST) shares jumped 1067% to $2.80 after the company released new data demonstrating superiority of TPST-1120 arm across multiple study endpoints in first-line hepatocellular carcinoma study.

ABAT